PLEDGE AGREEMENTPledge Agreement • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • New York
THIS PLEDGE AGREEMENT (this “Agreement”), dated as of March 20, 2006, is by and between CardioVascular BioTherapeutics, Inc., a Delaware corporation (“Pledgor”), and Promethean Asset Management L.L.C., a Delaware limited liability company, acting in its capacity as collateral agent (the “Pledgee”) for the benefit of the “Lenders” (as such term is defined below).
GUARANTYGuaranty • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations
THIS GUARANTY (this “Guaranty”) is made as of this day of , 20 , by [NAME OF GUARANTOR] (each such entity, together with each other person or entity who becomes a party to this Guaranty by execution of a joinder in the form of Exhibit A attached hereto, is referred to individually as a “Guarantor” and collectively as the “Guarantors”) in favor of Promethean Asset Management L.L.C., on its own behalf and in its capacity as collateral agent (together with its successors and assigns in such capacity, the “Collateral Agent”) for the benefit of the entities identified on the Schedule of Buyers attached to the Purchase Agreement defined below (together with their successors and assigns, the “Lenders”).
GUARANTYGuaranty • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations
THIS GUARANTY (this “Guaranty”) is made as of this 20th day of March, 2006, by DANIEL C. MONTANO, an individual residing at 2877 Paradise Road, Unit 901, Las Vegas, NV 89109 (the “Guarantor”) in favor of PROMETHEAN ASSET MANAGEMENT L.L.C., on its own behalf and in its capacity as collateral agent (together with its successors and assigns in such capacity, the “Collateral Agent”) for the benefit of the entities identified on the Schedule of Buyers attached to the Purchase Agreement defined below (together with their successors and assigns, the “Lenders”).
SECURITY AGREEMENTSecurity Agreement • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • New York
THIS SECURITY AGREEMENT (“Agreement”) dated as of March 20, 2006 among CardioVascular BioTherapeutics, Inc., a Delaware corporation (“Borrower”; and together with each other Person who becomes a party to this Agreement by execution of a joinder in the form of Exhibit A attached hereto, is referred to individually as a “Debtor” and, collectively, as the “Debtors”), and Promethean Asset Management L.L.C., a Delaware limited liability company, in its capacity as collateral agent for the Lenders on Schedule B attached hereto (together with their respective successors and assigns, “Lenders”) and their respective successors and assigns (together with its successors and assigns in such capacity, the “Secured Party”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of March 20, 2006, by and among CardioVascular BioTherapeutics, Inc., a Delaware corporation, with headquarters currently located at 7251 West Lake Mead Boulevard, Suite 303, Las Vegas, Nevada 89128, to be relocated to 1635 Village Center Circle, Suite 250, Las Vegas, Nevada 89134, effective April 1, 2006 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
PATENT SECURITY AGREEMENTPatent Security Agreement • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations
THIS PATENT SECURITY AGREEMENT (the “Agreement”) made as of this 20th day of March, 2006, by CARDIOVASCULAR BIOTHERAPEUTICS, INC., a Delaware corporation (“Grantor”) in favor of Promethean Asset Management L.L.C., on its own behalf and in its capacity as collateral agent (together with its successors and assigns in such capacity, the “Grantee”) for the benefit of the entities identified on the Schedule of Buyers attached to the Purchase Agreement defined below (together with their successors and assigns, the “Lenders”):
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 22nd, 2006 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • New York
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of March 20, 2006, by and among CardioVascular BioTherapeutics, Inc., a Delaware corporation, with headquarters currently located at 7251 West Lake Mead Boulevard, Suite 303, Las Vegas, Nevada 89128, to be relocated to 1635 Village Center Circle, Suite 250, Las Vegas, Nevada 89134, effective April 1, 2006 (the “Company”), and the undersigned buyers (each, a “Buyer” and collectively, the “Buyers”).
